Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug - Wikidata - awgldk - TriplyDB

Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug

Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug

http://www.wikidata.org/entity/Q35821866

about

Nanotechnology-based drug delivery systems for treatment of oral cancer: a review Nanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions.Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid.Cancer drug delivery in the nano era: An overview and perspectives (Review)Nanostructured lipid carriers employing polyphenols as promising anticancer agents: Quality by design (QbD) approach.Quercetin-imprinted nanospheres as novel drug delivery devices Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases.Inhibition of Zymosan-Induced Inflammatory Factors Expression by ATRA Nanostructured Lipid Carriers.Nanostructured lipid carriers as a delivery system of biochanin A.Nanocarrier-mediated delivery of α-mangostin for non-surgical castration of male animals.All-trans retinoic acid-loaded lipid nanoparticles as a transdermal drug delivery carrier.An Abraded Surface of Doxorubicin-Loaded Surfactant-Containing Drug Delivery Systems Effectively Reduces the Survival of Carcinoma Cells.Zerumbone-Loaded Nanostructured Lipid Carrier Induces Apoptosis of Canine Mammary Adenocarcinoma Cells Comparison of Apoptotic Inducing Effect of Zerumbone and Zerumbone-Loaded Nanostructured Lipid Carrier on Human Mammary Adenocarcinoma MDA-MB-231 Cell Line

P2860

Q26995835-64543AED-E132-47E4-B8CB-E580E6360F44 Q33962553-CC73CBFA-9616-4ED3-BC5B-D331229EA43D Q36253332-611B8FB4-879B-45F0-8420-145E26D34F3C Q38669454-8FAB6A7A-63FF-4544-A057-4EE2C35C4714 Q39305508-2AE0E8BB-15B5-4FAD-93E3-ADBD37C333BF Q40388738-09917A2F-356C-4D29-A3C7-10EC35A77624 Q42321490-F7443349-ED37-4A1A-99E0-09A6517DBF6B Q42577077-BD472CD9-B357-4885-8A97-158C426FD651 Q45415768-4971A83F-5991-42EB-8230-12D28E49C768 Q47140533-0D700DD2-6D8F-45C9-A6EF-BCE99F5348BD Q50484785-D1EAC5DE-71DA-4755-B42D-B7D8B5CCB3E9 Q50865516-BA4F74CC-619D-4800-A355-84A843C8F434 Q58560822-93B32B95-9768-465C-BEE5-783C9F0ACF8D Q59059048-AB4F401F-732E-4A43-850C-747A09040DD1

P2860

Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug

http://www.wikidata.org/entity/Q35821866

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug

@ast

Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug

@en

type

label

Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug

@ast

Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug

@en

prefLabel

Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug

@ast

Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug

@en

P1433

Q35821866-9B8DC319-F704-47E6-8283-2C0A74B858FD

P1476

Q35821866-D329F1A7-14E6-4B12-8093-E40E846442F7

P2093

Q35821866-15A48B88-73A2-4C0A-8881-A1D421FEEC5F

Q35821866-6B0AB331-336E-4F33-97F7-F5E48BB989AD

Q35821866-6CE8FB56-1436-4606-B1B9-6572DB3CD61B

Q35821866-7C1A53DD-4BDE-4161-BF8C-974E21324755

Q35821866-ADD0EFF7-6154-4BF6-8FB2-F13ED034EED5

Q35821866-D0B9B710-0DF1-4007-8F6E-F87676EBF9F2

Q35821866-FE7C0E44-5B90-4BF1-8D52-6BE641AF2886

P2860

Q35821866-09090215-8EDC-48A4-AF85-578DD565546D

Q35821866-12420927-F1A1-444B-94AD-BDA31009BFC6

Q35821866-13FF591A-BC57-410B-87DF-C8F1C181476B

Q35821866-1C2630DB-D423-49D3-B704-5A2FE951B209

Q35821866-304FB7B3-A700-4CD2-9FBC-25F6280353AA

Q35821866-3CE6D24C-AB0E-4A52-863C-DB86FC141EAF

Q35821866-41317CF8-AEE9-4BD1-A421-75E41AD12166

Q35821866-4264AAE2-AD61-4295-8141-09FCCDB8CA7C

Q35821866-43334CA7-5D94-4BB6-B218-F3CAB2CC5662

Q35821866-837053C8-247E-4B10-B8E7-60B253F160D4

P2888

Q35821866-427DD97D-62FA-4465-BBBF-B8D7823A1643

P304

Q35821866-4FB6BD64-3658-458E-9851-B365E8E223D9

P31

Q35821866-E718CABB-1F69-4983-87A2-7450542D8A2E

P356

Q35821866-ED7A8A2B-9B4B-42FA-958A-FF8EF0C43CB5

P407

Q35821866-8C3C766C-3E17-4A27-B8D6-A13035AECF19

P433

Q35821866-A8899AE8-B6FB-4B6A-A63D-5823D1651D3D

P478

Q35821866-9CA5C11B-4B3E-4D90-BDCB-96AE84DC185C

P577

Q35821866-291EBE7C-8F7D-4ADC-A5EE-84BD72317335

P5875

Q35821866-73D8D5BD-C620-49ED-996E-EF3B2349060B

P6179

Q35821866-3872BD17-B6B5-4CB6-8809-789991FA5586

P698

Q35821866-9E92C9C2-339F-4AB9-AA1D-78AF2D723B47

P932

Q35821866-ADB18FD2-AF79-4CC0-9A09-552351C52DBC

P356

S12249-011-9733-8

P1433

AAPS PharmSciTech

P1476

Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug

@en

P2093

Akhayacatra Chinsriwongkul

http://www.w3.org/2001/XMLSchema#string

Ponwanit Chareanputtakhun

http://www.w3.org/2001/XMLSchema#string

Praneet Opanasopit

http://www.w3.org/2001/XMLSchema#string

Tanasait Ngawhirunpat

http://www.w3.org/2001/XMLSchema#string

Theerasak Rojanarata

http://www.w3.org/2001/XMLSchema#string

Uracha Ruktanonchai

http://www.w3.org/2001/XMLSchema#string

Warisada Sila-on

http://www.w3.org/2001/XMLSchema#string

P2860

Niosomes as carriers for tretinoin. I. Preparation and properties.

Solid lipid nanoparticles: production, characterization and applications.

Retinoids and their receptors in cancer development and chemoprevention.

Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.

All-trans-retinoic acid nanodisks.

Lipid nanoparticles for parenteral delivery of actives.

Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.

Evaluation of the pharmacokinetics of all-trans-retinoic acid (ATRA) in Wistar rats after intravenous administration of ATRA loaded into tributyrin submicron emulsion and its cellular activity on caco-2 and HepG2 cell lines.

Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.

Apoptotic events induced by naturally occurring retinoids ATRA and 13-cis retinoic acid on human hepatoma cell lines Hep3B and HepG2.

P2888

s12249-011-9733-8

P304

150-158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/S12249-011-9733-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51876496

http://www.w3.org/2001/XMLSchema#string

P6179

1014888752

http://www.w3.org/2001/XMLSchema#string

P698

22167418

http://www.w3.org/2001/XMLSchema#string

P932

3299450

http://www.w3.org/2001/XMLSchema#string